2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.
However, long-term investors know that one quarterly report rarely changes the fundamental investment thesis of a corporation. It's nice to have money invested in excellent equities that should perform well no matter what happens in the next few weeks.
Let's consider two growth stocks that fit the bill: Eli Lilly (NYSE: LLY) and (NASDAQ: DXCM).
Source Fool.com
Dexcom Inc. Stock
€119.28
0.880%
Dexcom Inc. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
With a target price of 136 € there is a slightly positive potential of 14.02% for Dexcom Inc. compared to the current price of 119.28 €.
